Durable response to immunotherapy plus chemotherapy in a patient with untreated, brain-metastatic, EGFR exon 20 insertion mutation lung adenocarcinoma: A case report

RATIONAL: Epidermal growth factor receptor (EGFR) 20 exon insertion is the second most common EGFR aberrations in non-small cell lung cancer (NSCLC). Despite some novel EGFR inhibitors, clinically obtainable management for this subset of patients remains an unmet need. there are no previous reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Nong, Jingying, Gu, Yanfei, Yao, Shuyang, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294870/
https://www.ncbi.nlm.nih.gov/pubmed/34398022
http://dx.doi.org/10.1097/MD.0000000000026650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294870/
https://www.ncbi.nlm.nih.gov/pubmed/34398022
http://dx.doi.org/10.1097/MD.0000000000026650

Ejemplares similares